AAV-PHP.B1 Serotype
First-generation blood-brain barrier penetrating AAV variant evolved from AAV9 using CREATE methodology. Mouse strain-specific due to LY6A receptor dependence.
| Tropism | CNS (widespread), peripheral nervous system (mouse-specific) |
|---|
Characteristics
Seven-amino acid insertion (TLAVPFK) in capsid position 588. 40-fold enhanced BBB penetration versus AAV9 in C57BL/6 mice. LY6A receptor-dependent CNS entry. Mouse strain-specific efficacy. Limited translation to primates.
Applications
CNS gene therapy in mouse models. Neurological disease research. Circuit mapping tools. Proof-of-concept for BBB-penetrating AAV engineering.
Sequence1 bp
Sign in to view the full sequence.
Sign inReferences
- 1.Hordeaux et al. (2019). The GPI-linked protein LY6A drives AAV-PHP.B transport across the blood-brain barrier. Mol Ther — Hordeaux 2019 LY6A BBB
- 2.Deverman et al. (2016). Cre-dependent selection yields AAV variants for widespread gene transfer to the adult brain. Nat Biotechnol — Deverman 2016 PHP.B
